Literature DB >> 14740424

Laboratory investigations useful in giant cell arteritis and Takayasu's arteritis.

C Salvarani1, F Cantini, L Boiardi, G G Hunder.   

Abstract

A raised erythrocyte sedimentation rate (ESR) is considered a hallmark for the diagnosis of giant cell arteritis (GCA). The American College of Rheumatology 1990 criteria for GCA include ESR greater than or equal to 50 mm/h as one of the five criteria. Although the presence of a normal ESR made GCA less likely, the results of a population-based study showed that the occurrence of a low/normal value in GCA at diagnosis is not rare. Pre-treatment ESR may be a prognostic indicator for duration of treatment. C-reactive protein (CRP) and interleukin-6 (IL-6) may be more sensitive indicators of disease activity than ESR in GCA patients. However, it is unclear whether the use in clinical practice of CRP and IL-6 has some apparent advantage over ESR. ESR is the most often used tool to assess disease activity in Takayasu's arteritis (TA). However, some studies have found that ESR and CRP are not able to differentiate patients with clinically active and inactive TA. Furthermore, histopathological studies have shown that over 40% of patients thought to be in clinical remission with normal acute phase reactants have active arteritis. IL-6 could be a promising marker of disease activity in TA; however, further studies are required to confirm its usefulness in clinical practice. Other laboratory investigations could be useful in the diagnosis or follow-up of GCA and TA, but more studies are required.

Entities:  

Mesh:

Year:  2003        PMID: 14740424

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  29 in total

Review 1.  Aneurysmatic disease in patients with Takayasu disease: a case review.

Authors:  S Perrotta; G Rådberg; A Perrotta; S Lentini
Journal:  Herz       Date:  2011-11-11       Impact factor: 1.443

Review 2.  Aortitis.

Authors:  Heather L Gornik; Mark A Creager
Journal:  Circulation       Date:  2008-06-10       Impact factor: 29.690

3.  Serum amyloid A as a marker of disease activity and treatment response in Takayasu arteritis.

Authors:  Aswin M Nair; Ruchika Goel; M Hindhumati; K Jayakanthan; J Visalakshi; George Joseph; Sumita Danda; Debashish Danda
Journal:  Rheumatol Int       Date:  2017-08-11       Impact factor: 2.631

4.  Pulmonary artery involvement in Takayasu arteritis: a retrospective study in Chinese population.

Authors:  Xin Xi; Juan Du; Jiayi Liu; Guangfa Zhu; Guanming Qi; Lili Pan
Journal:  Clin Rheumatol       Date:  2020-07-08       Impact factor: 2.980

5.  Markers of endothelial damage and repair in Takayasu arteritis: are they associated with disease activity?

Authors:  Serkan Dogan; Ozden Piskin; Dilek Solmaz; Servet Akar; Aytac Gulcu; Faize Yuksel; Volkan Cakır; Ismail Sari; Nurullah Akkoc; Fatos Onen
Journal:  Rheumatol Int       Date:  2014-01-12       Impact factor: 2.631

6.  Evaluation of Potential Serum Biomarkers of Disease Activity in Diverse Forms of Vasculitis.

Authors:  Alicia Rodriguez-Pla; Roscoe L Warner; David Cuthbertson; Simon Carette; Nader A Khalidi; Curry L Koening; Carol A Langford; Carol A McAlear; Larry W Moreland; Christian Pagnoux; Philip Seo; Ulrich Specks; Antoine G Sreih; Steven R Ytterberg; Kent J Johnson; Peter A Merkel; Paul A Monach
Journal:  J Rheumatol       Date:  2019-09-01       Impact factor: 4.666

Review 7.  Clinical features of polymyalgia rheumatica and giant cell arteritis.

Authors:  Carlo Salvarani; Nicolò Pipitone; Annibale Versari; Gene G Hunder
Journal:  Nat Rev Rheumatol       Date:  2012-07-24       Impact factor: 20.543

8.  Serum amyloid A is a useful marker to evaluate the disease activity of Takayasu's arteritis.

Authors:  Tomohiro Koga; Yuichiro Nishino; Junya Makiyama; Takeshi Hayashida; Taichiro Miyashita; Yasumori Izumi; Mami Tamai; Atsushi Kawakami; Katsumi Eguchi; Kiysohi Migita
Journal:  Rheumatol Int       Date:  2009-12-18       Impact factor: 2.631

9.  Perfusion-based assessment of disease activity in untreated and treated patients with aortitis and chronic periaortitis: correlation with CT morphological, clinical and serological data.

Authors:  Georg Bier; Jörg Henes; Carolin Eulenbruch; Theodoros Xenitidis; Konstantin Nikolaou; Marius Horger
Journal:  Br J Radiol       Date:  2015-10-01       Impact factor: 3.039

10.  Development of a Core Set of Outcome Measures for Large-vessel Vasculitis: Report from OMERACT 2016.

Authors:  Antoine G Sreih; Fatma Alibaz-Oner; Tanaz A Kermani; Sibel Z Aydin; Peter F Cronholm; Trocon Davis; Ebony Easley; Ahmet Gul; Alfred Mahr; Carol A McAlear; Nataliya Milman; Joanna C Robson; Gunnar Tomasson; Haner Direskeneli; Peter A Merkel
Journal:  J Rheumatol       Date:  2017-09-01       Impact factor: 4.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.